Yüklüyor......
Profile of eliglustat tartrate in the management of Gaucher disease
Gaucher disease (GD) is a lysosomal storage disorder caused by the deficient activity of acid beta glucosidase, with consequent accumulation of glucosylceramide in the spleen, liver, bone marrow, and various organs and tissues. Currently, the gold standard for GD treatment is enzyme replacement ther...
Kaydedildi:
| Yayımlandı: | Ther Clin Risk Manag |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714736/ https://ncbi.nlm.nih.gov/pubmed/26811686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S73226 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|